<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 8-K
--------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) OCTOBER 26, 2000
------------------------
ALEXION PHARMACEUTICALS, INC.
-----------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
DELAWARE 0-27756 13-3648318
---------- --------- ------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
25 SCIENCE PARK, NEW HAVEN, CT 06511
---------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (203) 776-1790
--------------------
NOT APPLICABLE
------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
ITEM 5. OTHER EVENTS
On October 26, 2000, the Company entered into an agreement to sell
2,300,000 shares of common stock to US Bancorp Piper Jaffray. The sale is made
under its recent shelf-registration statement (Registration No. 333-47594 filed
October 6, 2000) relating to the possible sale from time to time of the
Company's securities. This Form 8-K is filed to incorporate the exhibits hereto
into that registration statement.
On October 27, 2000, Alexion Pharmaceuticals, Inc. issued the press
release filed herewith as Exhibit 99.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) EXHIBITS.
1 Purchase Agreement, dated October 26, 2000, among Alexion
Pharmaceuticals, Inc. and US Bancorp Piper Jaffray.
99 Press Release dated October 27, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ALEXION PHARMACEUTICALS, INC.
Date: October 27, 2000 By: /s/ LEONARD BELL
----------------------
Name: Leonard Bell, M.D.
Title: President, Chief Executive
Officer, Secretary and Treasurer
